A recent article in the Indianapolis Recorder featured USA Fibroid Centers for its extensive clinical study, released on April 1, 2025, involving 1,285 patients. The study reinforces Uterine Artery Embolization (UAE), also known as UFE, as a major advancement and superior option for many women, offering a minimally invasive outpatient procedure.
Dr. Yan Katsnelson, MD, CEO of USA Fibroid Centers, emphasized that the study proves that UAE is a safer and far more effective fibroid treatment option for many women out there. The procedure has been shown to help shrink fibroids by blocking blood flow, leading to significant symptom relief and improved quality of life for a high percentage of participants.
The article also talks about the significant impact of uterine fibroids, particularly among Black women, while elaborating on promising treatment advancements.
For more details, read the full article: Hidden pain: Fighting fibroids in Indianapolis